Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2023 Aug 15;14:1272763. doi: 10.3389/fimmu.2023.1272763

Expression of Concern: The immunobiogram, a novel in vitro assay to evaluate treatment resistance in patients receiving immunosuppressive therapy

Frontiers Editorial Office*
PMCID: PMC10502157  PMID: 37720235

With this notice, Frontiers states its awareness of concerns regarding the authorship of “The Immunobiogram, a Novel In Vitro Assay to Evaluate Treatment Resistance in Patients Receiving Immunosuppressive Therapy” published on 25 January 2021. Specifically, concerns have been raised that three individuals, Veronica Sánchez Rodríguez, Marianna di Scala, and Javier Dotor, have been excluded from the author list. An investigation was conducted in line with COPE guidelines involving the authors’ institution and the funding body, but unfortunately no conclusion could be reached.

This Expression of Concern was approved by the Chief Editors of Frontiers in Immunology and the Chief Executive Editor of Frontiers. The authors do not agree to this Expression of Concern.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES